- Paragon Care (PGC) has appointed Mark Hooper as group chief executive officer (CEO) and managing director of the company
- Mark Hooper is the current CEO of Sigma Healthcare, announcing his tendered resignation after almost 11 years
- Over the past decade, Mark Hooper has led Sigma through a major divestment of the pharmaceutical division and several acquisitions, as well as a major internal transformation project to generate operating efficiencies of over $100 million
- The company says Mr Hooper joins at an exciting time, following the planned merger with Quantum Health in Q3 FY22
- Paragon Care shares are down 1.54 per cent to trade at 32 cents at 1:54 pm AEDT
Paragon Care (PGC) has appointed Mark Hooper as group chief executive officer (CEO) and managing director of the company.
Mark Hooper is the current CEO of Sigma Healthcare (SIG), announcing his tendered resignation after almost 11 years.
Mr Hooper will continue in his role with Sigma until December 31 and commence his role with Paragon Care on April 5.
Over the past decade, Mark Hooper has led Sigma through a major divestment of the pharmaceutical division and several acquisitions, as well as a major internal transformation project to generate operating efficiencies of over $100 million.
The company says prior to Sigma, Mr Hooper has a range of experience in finance, commercial and operational roles, as well as CEO and executive director of PaperlinX and CEO and COO of Symbion Health Limited.
Paragon Care chair, Shane Tanner, says Mr Hooper joins the company at an exciting time.
“Mark’s career in healthcare has been extensive and he has few peers in the Australian market,” he said.
“As Paragon Care expands into Asia following the merger with Quantum Health, having someone with Mark’s capacity to drive growth will be invaluable.
“Our current CEO, Phil Nicholl, will remain focused on growing the business in Australia and New Zealand and John Walstab, current Managing Director at Quantum Health will be focused on further expansion in Asia.”
Mark Hooper said he looks forward to working with the team at Paragon Care to identify new growth opportunities and to execute on the next phase of the growth strategy.
“I am very excited to be joining Paragon Care at the early stages of its Asian expansion
strategy, as the Company upgrades manufacturing capacity and scales operations through the merger with Quantum Health,” Mr Hooper said.
Paragon Care shares are down 1.54 per cent to trade at 32 cents at 1:54 pm AEDT.